Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
1994 • 8,631 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 • 7,378 citations
Regulation of the mevalonate pathway
1990 • 5,282 citations
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
1995 • 3,524 citations
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
1975 • 3,075 citations
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 • 2,839 citations
EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)
1989 • 2,639 citations
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 • 2,192 citations
Dietary Intake and Cell Membrane Levels of Long-Chain n-3 Polyunsaturated Fatty Acids and the Risk of Primary Cardiac Arrest
1995 • 911 citations
Modulation of membrane function by cholesterol
1991 • 344 citations
Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis
1975 • 163 citations
Low phospholipid arachidonic acid values in diabetic platelets.
1983 • 90 citations
Lovastatin increases arachidonic acid levels and stimulates thromboxane synthesis in human liver and monocytic cell lines.
1994 • 41 citations
Short-term diabetic ketosis alters n-6 polyunsaturated fatty acid content in plasma phospholipids.
1996 • 27 citations
Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
1998 • 23 citations
Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.
1991 • 16 citations
Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia
1995 • 12 citations